Last reviewed · How we verify
Human Rotavirus Vaccine
Human Rotavirus Vaccine is a Biologic drug developed by PATH. It is currently FDA-approved. Also known as: Rotarix.
At a glance
| Generic name | Human Rotavirus Vaccine |
|---|---|
| Also known as | Rotarix |
| Sponsor | PATH |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults (PHASE1)
- CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults (PHASE1)
- A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants (PHASE3)
- Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand (PHASE3)
- Infant Malaria Vaccine Schedule Optimization (PHASE2)
- Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa (PHASE2)
- Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks (PHASE3)
- Optimising Rotavirus Vaccine in Aboriginal Children (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Human Rotavirus Vaccine CI brief — competitive landscape report
- Human Rotavirus Vaccine updates RSS · CI watch RSS
- PATH portfolio CI
Frequently asked questions about Human Rotavirus Vaccine
What is Human Rotavirus Vaccine?
Human Rotavirus Vaccine is a Biologic drug developed by PATH.
Who makes Human Rotavirus Vaccine?
Human Rotavirus Vaccine is developed and marketed by PATH (see full PATH pipeline at /company/path).
Is Human Rotavirus Vaccine also known as anything else?
Human Rotavirus Vaccine is also known as Rotarix.
What development phase is Human Rotavirus Vaccine in?
Human Rotavirus Vaccine is FDA-approved (marketed).
Related
- Manufacturer: PATH — full pipeline
- Also known as: Rotarix